Combining genetic information from tumor cells with 3-D cell cultures grown from these tumors, and rapidly screening approved drugs, can identify the best treatment approaches in patients.
Dr. Juan R. Cubillos-Ruiz and Dr. Dan Landau have won Stand Up to Cancer (SU2C) grants totaling nearly $1.5 million for innovative research projects in ovarian cancer and combination cancer therapy.
Weill Cornell Medicine celebrated a successful Match Day, with 94 percent of the class matching to postgraduate positions at academic medical centers ranked in the top 50 by U.S. News and World Report.
ILR School Professor Sam Bacharach and his colleagues have filmed the personal stories of recovering alcoholics as they reflect on their lives and struggle to remain sober. (Sept. 9, 2009)
Researchers at Weill Cornell Medical College have discovered that a known biomarker of bone mineral density also can be used to monitor the effects of testosterone therapy in men who suffer from osteoporosis.
Susan Daniel and Gary Whittaker discuss their collaborations and others across Cornell’s campuses that are working to better understand the COVID-19 virus.
A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments.
Center for Advanced Technology awards support Cornell life science faculty and research associates to develop biotechnologies with commercial potential.
Surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are the first in the New York City metropolitan area to successfully implant into the brain arteries a new stent specifically designed to treat high-risk stroke patients.